Create Medic Co., Ltd. (TYO:5187)
Japan · Delayed Price · Currency is JPY 1,140.00
-9.00 (-0.78%)
Aug 3, 2026, 3:13 PM JST
Create Medic Cash Flow Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 1,060 | 1,086 | 904 | 836 | 965 |
Depreciation & Amortization | 570 | 636 | 588 | 600 | 462 |
Loss (Gain) From Sale of Assets | 125 | -297 | 5 | -3 | 5 |
Loss (Gain) From Sale of Investments | - | 29 | 24 | - | 75 |
Other Operating Activities | -387 | -277 | -333 | -401 | -254 |
Change in Accounts Receivable | -167 | 272 | 100 | 37 | -167 |
Change in Inventory | -503 | 582 | -346 | -505 | 77 |
Change in Accounts Payable | -212 | 192 | 55 | -86 | 4 |
Change in Other Net Operating Assets | 44 | 26 | -299 | -17 | 81 |
Operating Cash Flow | 530 | 2,249 | 698 | 461 | 1,248 |
Operating Cash Flow Growth | -76.43% | 222.21% | 51.41% | -63.06% | -0.08% |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -415 | -384 | -435 | -260 | -299 |
Sale of Property, Plant & Equipment | -16 | 772 | 86 | 21 | - |
Sale (Purchase) of Intangibles | -30 | -92 | -16 | -99 | -320 |
Investment in Securities | -110 | -20 | - | 371 | 36 |
Other Investing Activities | -2 | -6 | 2 | 5 | -2 |
Investing Cash Flow | -573 | 270 | -363 | 38 | -585 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Repaid | -800 | - | - | - | - |
Long-Term Debt Repaid | - | - | - | - | -92 |
Total Debt Repaid | -800 | - | - | - | -92 |
Net Debt Issued (Repaid) | -800 | - | - | - | -92 |
Issuance of Common Stock | 744 | - | - | 4 | - |
Repurchase of Common Stock | -200 | -499 | - | - | - |
Common Dividends Paid | -314 | -348 | -335 | -336 | -335 |
Other Financing Activities | -30 | -30 | -27 | -23 | -15 |
Financing Cash Flow | -600 | -877 | -362 | -355 | -442 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 41 | 248 | 95 | 144 | 109 |
Miscellaneous Cash Flow Adjustments | 1 | 1 | - | - | - |
Net Cash Flow | -601 | 1,891 | 68 | 288 | 330 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 115 | 1,865 | 263 | 201 | 949 |
Free Cash Flow Growth | -93.83% | 609.13% | 30.85% | -78.82% | -7.05% |
Free Cash Flow Margin | 0.84% | 14.31% | 2.09% | 1.64% | 8.11% |
Free Cash Flow Per Share | 13.01 | 211.60 | 28.89 | 22.09 | 104.34 |
Levered Free Cash Flow | -302.25 | 1,432 | 276.63 | 333.88 | -3.88 |
Unlevered Free Cash Flow | -297.88 | 1,438 | 282.88 | 338.25 | -0.13 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 7 | 11 | 11 | 5 | 6 |
Cash Income Tax Paid | 386 | 278 | 333 | 408 | 254 |
Change in Working Capital | -838 | 1,072 | -490 | -571 | -5 |